| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1386-6346(03)00115-3 |
| P698 | PubMed publication ID | 12787797 |
| P2093 | author name string | David R. Brigstock | |
| Amy W. Rachfal | |||
| P433 | issue | 1 | |
| P921 | main subject | connective tissue | Q25615 |
| P304 | page(s) | 1-9 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Hepatology Research | Q15752035 |
| P1476 | title | Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis | |
| P478 | volume | 26 |
| Q28569215 | A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis |
| Q37209120 | A virus-like particle-based connective tissue growth factor vaccine suppresses carbon tetrachloride-induced hepatic fibrosis in mice |
| Q24815319 | Activation of nuclear factor kappa B (NF-kappaB) by connective tissue growth factor (CCN2) is involved in sustaining the survival of primary rat hepatic stellate cells |
| Q34441588 | Activation of the connective tissue growth factor (CTGF)-transforming growth factor β 1 (TGF-β 1) axis in hepatitis C virus-expressing hepatocytes |
| Q37353099 | Advances in antifibrotic therapy |
| Q28570375 | All-trans retinoic acid diminishes collagen production in a hepatic stellate cell line via suppression of active protein-1 and c-Jun N-terminal kinase signal |
| Q61812575 | An Inhibitor of Arginine-Glycine-Aspartate-Binding Integrins Reverses Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis |
| Q39658750 | Analysis of Secreted Proteins as an in vitro Model for Discovery of Liver Toxicity Markers |
| Q53547058 | Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury. |
| Q53801446 | Beneficial effects of soluble dietary Jerusalem artichoke (Helianthus tuberosus) in the prevention of the onset of type 2 diabetes and non-alcoholic fatty liver disease in high-fructose diet-fed rats. |
| Q50632027 | CCN family protein 2 (CCN2) promotes the early differentiation, but inhibits the terminal differentiation of skeletal myoblasts. |
| Q92406130 | CXCL16 Induces the Progression of Pulmonary Fibrosis through Promoting the Phosphorylation of STAT3 |
| Q26825671 | Chronic hepatitis C and liver fibrosis. |
| Q35435477 | Circulating adhesion molecules in patients with virus-related chronic diseases of the liver |
| Q45899263 | Coffee prevents CCl(4)-induced liver cirrhosis in the rat. |
| Q37304264 | Connective tissue growth factor hammerhead ribozyme attenuates human hepatic stellate cell function |
| Q51753112 | Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes--but without modulating bone morphogenetic protein 7 signaling. |
| Q54256411 | Connective tissue growth factor modulates extracellular matrix production in human subconjunctival fibroblasts and their proliferation and migration in vitro. |
| Q40616643 | Connective tissue growth factor participates in scar formation of crescentic glomerulonephritis. |
| Q34487143 | Connective tissue growth factor reacts as an IL-6/STAT3-regulated hepatic negative acute phase protein |
| Q53478090 | Connective tissue growth factor stimulates renal cortical myofibroblast-like cell proliferation and matrix protein production. |
| Q45337492 | Connective tissue growth factor/CCN-2 is upregulated in epididymal and subcutaneous fat depots in a dietary-induced obesity model |
| Q43528805 | Connective tissue growth factor: a predictor of recurrence after catheter ablation in patients with nonparoxysmal atrial fibrillation |
| Q35737521 | Connective-Tissue Growth Factor (CTGF/CCN2) Induces Astrogenesis and Fibronectin Expression of Embryonic Neural Cells In Vitro |
| Q46818402 | Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor |
| Q40221690 | Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis. |
| Q46584628 | Diffuse expression of heparan sulfate proteoglycan and connective tissue growth factor in fibrous septa with many mast cells relate to unresolving hepatic fibrosis of congenital hepatic fibrosis |
| Q33671258 | Enhanced Wnt Signalling in Hepatocytes is Associated with Schistosoma japonicum Infection and Contributes to Liver Fibrosis |
| Q37619724 | Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells |
| Q39620314 | Ethanol-stimulated differentiated functions of human or mouse hepatic stellate cells are mediated by connective tissue growth factor |
| Q35794328 | Evaluation of liver fibrosis: a concise review |
| Q51737857 | Evaluation of the cytokines IL-10 and IL-13 as mediators in the progression of Symmers fibrosis in patients with hepatosplenic schistosomiasis mansoni. |
| Q36014644 | Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options |
| Q57584307 | Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders |
| Q35868676 | Expression of connective tissue growth factor in the human liver with idiopathic portal hypertension |
| Q81628736 | Expression of growth factors in the conjunctiva from patients with active trachoma |
| Q89118320 | Fibroblast Growth Factor 2 as an Antifibrotic: Antagonism of Myofibroblast Differentiation and Suppression of Pro-Fibrotic Gene Expression |
| Q24644869 | Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers |
| Q53078393 | Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells. |
| Q24642303 | Functions and mechanisms of action of CCN matricellular proteins |
| Q37210050 | Genesis of hepatic fibrosis and its biochemical markers. |
| Q35918603 | Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice |
| Q53581215 | Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference. |
| Q29616840 | Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver |
| Q39633178 | Hepatitis C virus E2 protein induce reactive oxygen species (ROS)‐related fibrogenesis in the HSC‐T6 hepatic stellate cell line |
| Q38560320 | Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis? |
| Q33390722 | Increased Expression of Connective Tissue Growth Factor (CTGF) in Multiple Organs After Exposure of Non-Human Primates (NHP) to Lethal Doses of Radiation |
| Q47125278 | Increased YAP Activation Is Associated With Hepatic Cyst Epithelial Cell Proliferation in ARPKD/CHF. |
| Q34050895 | Increased expression of CCN2, epithelial membrane antigen, and fibroblast activation protein in hepatocellular carcinoma with fibrous stroma showing aggressive behavior |
| Q42632299 | Integrin expression and function in the response of primary culture hepatic stellate cells to connective tissue growth factor (CCN2). |
| Q47144532 | Kahweol decreases hepatic fibrosis by inhibiting the expression of connective tissue growth factor via the transforming growth factor-beta signaling pathway. |
| Q37554158 | Less Smad2 is good for you! A scientific update on coffee's liver benefits |
| Q35760670 | Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats |
| Q43055203 | MCP-1 downregulates MMP-9 export via vesicular redistribution to lysosomes in rat portal fibroblasts. |
| Q38637695 | MMP-13 deletion decreases profibrogenic molecules and attenuates N-nitrosodimethylamine-induced liver injury and fibrosis in mice. |
| Q36304061 | Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications |
| Q29619336 | Mechanisms of hepatic fibrogenesis |
| Q42263903 | Monocyte adhesion molecules expression in patients with chronic hepatitis C liver disease. |
| Q55395460 | NNMT activation can contribute to the development of fatty liver disease by modulating the NAD + metabolism. |
| Q50523966 | Oral application of 1,7-dimethylxanthine (paraxanthine) attenuates the formation of experimental cholestatic liver fibrosis |
| Q34593148 | Paeonol inhibits hepatic fibrogenesis via disrupting nuclear factor-κB pathway in activated stellate cells: in vivo and in vitro studies |
| Q35847494 | Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice |
| Q33522307 | Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors |
| Q37790160 | Potential applications for cell regulatory factors in liver progenitor cell therapy |
| Q49918430 | Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia/reperfusion injury |
| Q47131939 | Protective Effects of Moringa oleifera on HBV Genotypes C and H Transiently Transfected Huh7 Cells. |
| Q35823795 | Protective effects of extracts from Pomegranate peels and seeds on liver fibrosis induced by carbon tetrachloride in rats |
| Q91637785 | RNA-Seq Analysis Reveals Spatial and Sex Differences in Pectoralis Major Muscle of Broiler Chickens Contributing to Difference in Susceptibility to Wooden Breast Disease |
| Q33786810 | Recombinant expression, purification, and functional characterisation of connective tissue growth factor and nephroblastoma-overexpressed protein |
| Q50145564 | Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes |
| Q35026403 | Relationship between hepatic CTGF expression and routine blood tests at the time of liver transplantation for biliary atresia: hope or hype for a biomarker of hepatic fibrosis |
| Q36729090 | Role of CCN2/CTGF/Hcs24 in bone growth |
| Q26774309 | Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis |
| Q36698776 | Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis |
| Q41886058 | Role of connective tissue growth factor in oval cell response during liver regeneration after 2-AAF/PHx in rats |
| Q36849055 | Role of microsomal enzymes in development of alcoholic liver diseases |
| Q54609647 | SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment. |
| Q40005893 | SGK1-dependent upregulation of connective tissue growth factor by angiotensin II. |
| Q46815142 | SGK1-mediated fibronectin formation in diabetic nephropathy |
| Q58706816 | STROBE: The correlation of Cyr61, CTGF, and VEGF with polymyositis/dermatomyositis |
| Q40054478 | Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma. |
| Q44675090 | Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype. |
| Q36053014 | Structural and functional properties of CCN proteins |
| Q38884278 | Suppressive effect of SATB1 on hepatic stellate cell activation and liver fibrosis in rats |
| Q37331302 | Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes |
| Q40365592 | TGF-beta1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway |
| Q54667831 | TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling. |
| Q39977440 | Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats |
| Q36663411 | The anti-fibrotic effect of bone morphogenic protein-7(BMP-7) on liver fibrosis |
| Q50731057 | The antifibrogenic effect of (-)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells |
| Q53118858 | The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways. |
| Q28238359 | The biological hallmarks of ileal carcinoids |
| Q64248028 | The expression profile analysis of atrial mRNA in rats with atrial fibrillation: the role of IGF1 in atrial fibrosis |
| Q36744942 | Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c-JUN N-terminal kinase |
| Q81384202 | Transforming growth factor-beta pathway is activated in cholecystolithiasis |
| Q39412554 | Transforming growth factor-beta1 (TGFbeta1) stimulates connective tissue growth factor (CCN2/CTGF) expression in human gingival fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent mechanism: statins with forskolin block TGFbeta1-induced CCN |
| Q37402387 | Variants of CTGF are associated with hepatic fibrosis in Chinese, Sudanese, and Brazilians infected with schistosomes |
| Q41172648 | sPECAM-1 and sVCAM-1: Role in Pathogenesis and Diagnosis of Chronic Hepatitis C and Association with Response to Antiviral Therapy. |
| Q45866531 | siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats. |
Search more.